![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]()
Edinburgh, England (UPI) Aug 16, 2005 Scientists at the Universities of Edinburgh and Milan reportedly made the world's first pure nerve stem cells from human embryonic stem cells. Researchers told the BBC they hope the newly-created cells will eventually assist scientists in finding new treatments for diseases such as Parkinson's and Alzheimer's. Stem cells are so-called "master" cells that can become many kinds of tissue. Nerve stem cells are those that help build the brain and central nervous system. Steven Pollard of the University of Edinburgh told the BBC: "This is incredibly exciting in terms of curing disease. We may be able to create the disease in a dish. If we do that, we'll be able to better understand the disease and also to test drugs." Although the long-term goal is to use the artificially created cells to treat such illnesses as Alzheimer's and Parkinson's, the short-term use will be to test the effectiveness of newly created drugs. University of Edinburgh Professor Austin Smith, who led the research, told the BBC, "We're already talking with the bio-technology and bio-pharmaceutical companies about taking these cells into screening systems for new drugs." Community Email This Article Comment On This Article Related Links The Institute for Stem Cell Research SpaceDaily Search SpaceDaily Subscribe To SpaceDaily Express Stem Cells News - Suppliers and Applications
![]() ![]() Stratos Global recently announced it had taken a step closer toward the completion of the acquisition of Xantic, having received positive advice from the Works' Council in the Netherlands, and executed a definitive agreement to purchase Xantic from KPN and Telstra Corporation. |
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |